Microglia are not protective against cryptococcal meningitis

Mohamed, Sally H.; Fu, Man Shun; Hain, Sofia; Alselami, Alanoud; Vanhoffelen, Eliane; Li, Yanjian; Bojang, Ebrima; Lukande, Robert; Ballou, Elizabeth R.; May, Robin C.; Ding, Chen; Velde, Greetje Vande; Drummond, Rebecca A.

doi:10.1038/s41467-023-43061-0

Download PDF

Article
Open access
Published: 08 November 2023

Microglia are not protective against cryptococcal meningitis

Nature Communications volume 14, Article number: 7202 (2023) Cite this article

3087 Accesses
1 Citations
100 Altmetric
Metrics details

Subjects

Abstract

Microglia provide protection against a range of brain infections including bacteria, viruses and parasites, but how these glial cells respond to fungal brain infections is poorly understood. We investigated the role of microglia in the context of cryptococcal meningitis, the most common cause of fungal meningitis in humans. Using a series of transgenic- and chemical-based microglia depletion methods we found that, contrary to their protective role during other infections, loss of microglia did not affect control of Cryptococcus neoformans brain infection which was replicated with several fungal strains. At early time points post-infection, we found that microglia depletion lowered fungal brain burdens, which was related to intracellular residence of C. neoformans within microglia. Further examination of extracellular and intracellular fungal populations revealed that C. neoformans residing in microglia were protected from copper starvation, whereas extracellular yeast upregulated copper transporter CTR4. However, the degree of copper starvation did not equate to fungal survival or abundance of metals within different intracellular niches. Taken together, these data show how tissue-resident myeloid cells may influence fungal phenotype in the brain but do not provide protection against this infection, and instead may act as an early infection reservoir.

Gasdermin-D-dependent IL-1α release from microglia promotes protective immunity during chronic Toxoplasma gondii infection

Article Open access 23 July 2020

Fungal kinases and transcription factors regulating brain infection in Cryptococcus neoformans

Article Open access 23 March 2020

The roles of microglia in viral encephalitis: from sensome to therapeutic targeting

Article Open access 12 January 2021

Introduction

Tissue-resident macrophages populate every organ in the body and help maintain homoeostasis while also acting in an immune surveillance capacity to provide rapid responses to infection or injury. In the central nervous system (CNS), there are several populations of tissue-resident macrophages that associate with distinct anatomical locations, including the meninges (meningeal macrophages), blood vessels (perivascular macrophages) and the brain parenchyma (microglia)¹.

Microglia are the most numerous brain-resident macrophages. These cells derive from embryonic precursors and maintain their numbers by self-renewal, relying on signals via the CSF1R for survival¹. Microglia are critical for proper brain development by helping to prune neuronal synapses and clear cellular debris. In adulthood, one of the major functions of microglia is immune surveillance and front-line defence against brain infection. The CNS is susceptible to infection with many pathogens including bacteria, viruses, parasites and fungi. Microglia are ideally situated to respond rapidly to pathogens as they invade the brain. For example, microglia are required for protective immunity against neurotropic coronaviruses by shaping CD4 T-cell responses within the brain, since their depletion results in uncontrolled viral load and accelerated mortality². During infection with the parasite Toxoplasma gondii, microglia respond rapidly to produce the alarmin IL-1α, required to initiate immune cell infiltration and control of parasite infection³.

CNS infections with fungi are much rarer than those caused by other microbes, but are difficult to treat and frequently lethal. During brain invasion by Candida fungi, microglia depend on CARD9 to activate antifungal immune responses such as the production of neutrophil-attracting chemokines⁴. Consequently, human CARD9 deficiency is a primary immunodeficiency disorder that leads to life-threatening CNS Candida infections⁵.

While many pathogenic fungi are able to infect the human CNS, the most common species is Cryptococcus neoformans, leading to a disease called cryptococcal meningitis. Cryptococcal meningitis is a leading cause of death in HIV/AIDS patients and is an increasingly observed clinical complication in patients with underlying immune defects caused by iatrogenic interventions⁶. How microglia respond to this fungal infection is unclear. Some studies have observed uptake and survival of the fungus within microglia⁷, while others have shown robust microglia activation leading to expression of MHC Class II and iNOS following infiltration by IFNγ-producing CD4 T-cells to the CNS⁸ or following administration of immunotherapy⁹. Moreover, the microenvironment of the CNS and brain tissue has significant influence over C. neoformans morphology and growth responses. For example, C. neoformans is severely restricted of the micronutrient copper in the brain, but must deal with toxic copper levels in other organs such as the lung¹⁰. Whether tissue-resident macrophages drive these fungal adaptions by regulating access to micronutrients, and the impact of nutritional immunity to organ-specific immune responses, is not known.

We set out to understand the in vivo role of microglia during early infection with C. neoformans using a series of microglia depletion strategies. Our findings show that, contrary to other types of infections studied thus far, microglia do not provide protection against this fungal infection, but played significant roles in influencing the development of heterogeneity within fungal populations in this tissue.

Results

Microglia harbour intracellular fungi

C. neoformans can survive and replicate within macrophage phagosomes, aiding its evasion of the immune system and dissemination to the brain within monocytes^11,12. We first characterised the association between C. neoformans and brain-resident and recruited inflammatory myeloid cells, using a green fluorescent reporter C. neoformans strain, which allowed us to track fungal uptake by different myeloid cell populations in the brain in vivo using flow cytometry (Fig S1). These experiments revealed that ~5% of microglia became infected with C. neoformans (Fig. 1a). However, microglia were the most numerous infected cell type within the brain, with significantly greater numbers of infected microglia detected compared to neutrophils, monocytes and inflammatory macrophages (Fig. 1b). When examined as a proportion of total infected myeloid cells in the brain, microglia accounted for nearly half of all fungal-infected cells (Fig. 1c). Analysis of fungal localisation by histology showed that yeast were growing in the brain parenchyma, in close association or intracellularly in host cells, and within areas of tissue damage with little association with host cells (extracellular growth) (Fig. 1d). Confocal microscopy revealed that microglia with internalised yeast had a rounded, amoeboid morphology typical of activation¹. These infected cells were often found next to sites of tissue damage that housed large numbers of extracellular yeast (Fig. 1e). As infection progresses, large areas of tissue damage with extracellular yeast growth become more prominent (Fig. 1d, e). Indeed, quantification of the proportion of extracellular yeast (as determined by histology) was increased at day 6 post-infection compared to day 3 post-infection (Fig. 1f). We observed similar patterns of growth in the human brain. Pathology analysis of brain tissue from a patient who died from HIV-associated cryptococcal meningitis had areas of extensive tissue damage with large numbers of extracellular yeast, and in other areas, yeast were observed residing within immune cells (Fig. 1g). Taken together, this data shows that an intimate relationship exists between tissue-resident microglia and C. neoformans.

**Fig. 1: Microglia are hosts to intracellular fungi.**

Brain macrophages are not required for controlling C. neoformans infection

While the role of monocytes and inflammatory macrophages in the control of C. neoformans infections has been intensely studied, the role of tissue-resident myeloid cells is less well understood. Since we had observed a close relationship between brain-resident myeloid cells and C. neoformans during early infection with increasing extracellular growth late post-infection, we decided to definitively determine the role of CNS-resident myeloid cells at various time points post-infection using in vivo mouse models. For that, we used several depletion strategies and assessed their effects on control of fungal brain infection. First, we generated Cx3cr1-Cre^ER-iDTR^flox animals in which all long-lived CX3CR1⁺ cells in the brain are depleted following treatment with diphtheria toxin (Fig. 2a). Microglia highly express CX3CR1, and unlike other CX3CR1+ myeloid cells, microglia do not replenish from the bone marrow. Therefore, we can target expression of the diphtheria toxin receptor (DTR) to only long-lived cells by including a rest period in which peripheral immune cells turn over from the bone marrow (Fig. 2a). To examine the role of microglia during experimental C. neoformans infection, we used an intravenous infection model where yeast cells directly invade the CNS and bypass pulmonary immunity, allowing us to isolate host-fungal interactions within the CNS. Using Cx3cr1-Cre^ER-iDTR^flox mice, we found that depletion of CX3CR1^hiCD45^int microglia was maintained during fungal infection (Fig. 2b). Following C. neoformans challenge, we found that the depleted mice had significantly reduced brain fungal burdens but no difference in lung fungal burden (Fig. 2c), indicating that microglia depletion may have a protective effect. To confirm these findings, we employed an independent microglia depletion strategy using the CSF1R inhibitor, PLX5622 (Fig. 2e, f), which interrupts the CSF1R-dependent signalling required for microglia survival (Fig S2). We found that PLX5622-treated mice also had reduced fungal brain burdens compared to untreated controls early post-infection, whereas lung burdens remained unchanged (Fig. 2g). However, in contrast to the Cx3cr1-Cre^ER-iDTR^flox mice, we found no difference in fungal brain burdens at day 6 post-infection in PLX5622-treated mice (Fig. 2g). In both models, we found that microglia depletion had little or no impact on recruitment of inflammatory myeloid cells such as Ly6C^hi monocytes and neutrophils to the brain (Fig. 2d, h). Taken together, these data show that microglia do not provide protection against C. neoformans infection, and that depletion of these cells may support fungal growth at early time points.

**Fig. 2: Depletion of CNS-resident macrophages reduces fungal brain burden.**

Early fungal brain infection is primarily supported by microglia

PLX5622 treatment can also deplete other macrophages found within the CNS, including recruited inflammatory macrophages and CNS-resident meningeal macrophages^2,13 (Figs. 2h and S2). Moreover, the Cx3cr1-Cre^ER line has been shown to additionally target non-microglia populations in certain contexts^14,15. We hypothesised that differences in how these two models affected non-microglia populations may explain the different phenotypes we observed in control of C. neoformans infection at later time points post-infection. Therefore, we sought to generate a mouse model to enable specific depletion of microglia while leaving other CNS-resident and recruited inflammatory macrophages intact, to definitively determine the impact of microglia loss on control of C. neoformans brain infection.

Sall1 is a signature microglia gene that is specifically expressed by microglia but not by other CNS-resident or inflammatory macrophages¹⁶. We confirmed this specificity by generating Sall1^CreERR26^Ai14 transgenic mice, in which only microglia became labelled with dTomato following tamoxifen treatment (Fig. 3a, b). Sall1-dependent labelling of microglia was stable during C. neoformans infection and remained specific to this cell type (Fig. 3c). Therefore, Sall1 is a reliable marker for tissue-resident microglia that can be used to specifically target these cells during experimental C. neoformans infection. We next crossed Sall1^CreER animals with Csf1r^flox transgenic mice to delete CSF1R specifically in microglia. We found that Sall1^CreERCsf1r^flox mice had specific depletion of microglia but normal numbers of meningeal macrophages and other macrophage populations in the brain after tamoxifen treatment (Figs. 3d, e and S2). Importantly, these microglia-specific depleted mice had significantly reduced brain fungal burden at day 3 post-infection (Fig. 3f), in line with our other depletion models. At day 6 post-infection, there was no significant difference in fungal brain burden in microglia-depleted mice compared to wild-type littermate controls (Fig S3). Taken together, these data confirm that microglia do not provide protection against C. neoformans infection.

**Fig. 3: Specific microglia depletion reduces brain fungal burden.**

Microglia do not provide protection against a range of C. neoformans clinical isolates

Our experiments utilised the laboratory reference strain C. neoformans H99, a virulent serotype A strain that was originally isolated from a lymphoma patient at Duke University¹⁷. C. neoformans H99 has been widely used for infection studies and determining the mechanisms of intracellular invasion and residence, as well as generating fluorescent reporter strains and mutant libraries¹⁷. However, there is wide variation between clinical and environmental isolates of C. neoformans, as well as between laboratory reference strains¹⁷. These variations can have significant impact on host immune responses and fungal morphology¹⁸. We therefore examined the role of microglia for controlling infection in mice infected with different isolates of C. neoformans. We first chose to examine C. neoformans B3501, which is commonly used for infection studies as a serotype D reference strain^19,20. We found that microglia-deficient mice infected with B3501 had similar brain fungal burdens compared to microglia-sufficient controls (Fig. 3g). Since B3501 is a different serotype to H99, we next decided to test a recent clinical isolate of C. neoformans, Zc15, that is also serotype A but genetically distinct from H99²¹. Mice infected with Zc15 had ~10 fold less fungal brain burden compared with H99 (compare Fig. 3g with Fig. 2c, g), indicating that Zc15 has reduced virulence in mouse models of C. neoformans infection. However, the absence of microglia did not affect control of infection in mice infected with Zc15 (Fig. 3g). Taken together, these results confirm that microglia are not protective for controlling C. neoformans infection across multiple strain backgrounds.

Reduction of brain fungal infection in microglia-depleted mice is dependent on intracellular fungal growth

C. neoformans strain H99 has a profound ability to grow intracellularly within myeloid cells. Infection of microglia-deficient mice with this strain showed a reduction in fungal brain burden in multiple depletion models, but this was isolated to an early time point post-infection (Figs. 2 and 3). We hypothesised that this phenotype was the result of early intracellular growth of C. neoformans within microglia, particularly since we had observed an increased rate of extracellular fungal growth at later time points post-infection (Fig. 1f) and had found no significant difference in brain burdens of microglia-depleted mice at this time point in two of the models tested (Fig. 2g and S3). To determine the functional relevance of fungal intracellular survival within microglia at early time points post-infection, we used the rdi1∆ C. neoformans mutant (on the H99 background). This strain is unable to survive within macrophages but has normal growth rates in rich media²². Histological examination of mouse brains infected with the rdi1∆ mutant revealed primarily extracellular yeast in areas of tissue damage at 72 h post-infection, whereas wild-type yeast cells were both intracellular and extracellular at this time (Fig. 4a). Quantification of these images revealed that 51.9% of counted wild-type yeast were intracellular, compared to 8.6% for the rdi1∆ mutant (Fig. 4b). We infected mice that were either microglia-sufficient (untreated) or microglia-depleted (PLX5622) with wild-type or rdi1∆ C. neoformans, and then quantified brain fungal burden. Compared to wild-type C. neoformans, brain fungal burdens were significantly reduced with the rdi1∆ strain (Fig. 4c). Importantly, while microglia depletion caused a significant reduction in brain infection with the wild-type C. neoformans, there was no significant difference in brain fungal burdens between microglia-depleted mice and their untreated controls when infected with the rdi1∆ mutant (Fig. 4c). These data indicate that the reduction in brain fungal burden observed with microglia depletion is dependent on the ability of the fungus to survive intracellularly.

**Fig. 4: Loss of microglia does not affect brain infection with C. neoformans rdi1∆.**

C. neoformans is protected from copper starvation within microglia

Microglia provide protection against a variety of brain-invading pathogens, including other fungi⁴. The lack of an effect of microglia depletion on control of C. neoformans infection was therefore surprising, given that these cells become intracellularly infected with the fungus and are thought to be among the first responders to this infection within the brain. To better understand the relationship between C. neoformans and microglia, we examined the phenotype of fungal cells residing in microglia and compared to extracellular yeast populations. We decided to focus on nutrient acquisition pathways, since we hypothesised that microglia may be unable to restrict fungal access to micronutrients, thus providing a ‘safe haven’ for C. neoformans from starvation conditions found elsewhere in the brain which may explain why depletion of microglia at early time points reduced fungal brain infection.

Several micronutrients are restricted within the CNS including copper and iron, but whether CNS-resident macrophages participate in this restriction is not well understood. Indeed, copper is typically found bound within microglia, with extracellular concentrations at 2-3 orders of magnitude lower than intracellular concentrations²³. We therefore tested the cellular localisation of fungal starvation responses in the brain, focusing on copper since C. neoformans response to copper starvation in the brain is a driver of virulence²⁴. Under copper-starved conditions, C. neoformans upregulates expression of the copper importer CTR4 (Fig. 5a), which is critical for fungal growth and virulence within the CNS²⁴. We compared expression of CTR4 by intracellular yeast cells (within microglia) to extracellular yeast in the brain in vivo, by measuring expression of a GFP transgene under the control of the CTR4 promotor (C. neoformans ^pCTR4GFP) (Fig. 5b). We found that extracellular yeast had upregulated ^pCTR4GFP expression, in line with previous data that showed significant induction of this gene within the CNS¹⁰ (Fig. 5c, d). In contrast, we found that yeast associated with microglia had significantly reduced ^pCTR4GFP expression (Fig. 5c, d). To ensure these results were not an artefact of different fluorescent properties of yeast inside host cells versus free yeast, we normalised ^pCTR4GFP expression to a constitutively-expressed mCherry housekeeper. Normalised ^pCTR4GFP expression was similarly reduced in intracellular yeast compared to extracellular yeast (Fig. 5e). Taken together, our data show that there is significant heterogeneity in C. neoformans populations in the brain, which may be driven by access to nutrients and trace metals such as copper.

**Fig. 5: C. neoformans is protected from copper starvation when associated with microglia.**

C. neoformans CTR4 expression occurs at < 50 nM copper

We next took advantage of the pCTR4-GFP C. neoformans strain to estimate copper concentrations in the CNS. We inoculated copper-deficient growth media with C. neoformans pCTR4-GFP, added increasing doses of copper to the media and compared GFP fluorescence after 24 hours growth by flow cytometry. At 10μM copper, there was no detection of ^pCTR4GFP expression and yeast cells remained negative for GFP expression down to 100 nM copper (Fig. 5e). We began to detect expression of ^pCTR4GFP at 50 nM copper, where ~5% yeast cells were GFP+ (Fig. 5e). However, at 10 nM copper this rose significantly to ~90% GFP + , similar to the copper starved condition (Fig. 5e). These data indicate that CTR4 expression switches on at copper concentrations <50 nM and does not exhibit a graded expression across a range of copper concentrations. Based on these data, we estimate that copper concentrations in the extracellular compartment of the C. neoformans-infected brain are between 10-50 nM, whereas copper concentrations within C. neoformans-infected microglia may be 50-100 nM or higher.

C. neoformans undergoes copper starvation in brain macrophages

After confirming that microglia protected C. neoformans from copper starvation in the brain, we next analysed fungal expression of ^pCTR4GFP in other myeloid cell types to determine whether intracellular protection from copper starvation was unique to microglia. For that, we performed the same experiment as before using flow cytometry to determine the frequency of ^pCTR4GFP-positive yeast in the different cellular compartments. In contrast to yeast within microglia, we discovered that yeast internalised by macrophages in the brain had increased expression of ^pCTR4GFP, almost to the same levels as extracellular yeast (Fig. 6a). Intracellular fungi within recruited monocytes and neutrophils had variable levels of ^pCTR4GFP expression, which on average was intermediate between microglia and macrophages (Fig. 6a). Taken together, these data indicate that there is divergent access to copper between different myeloid cell types in the infected brain, resulting in variability in fungal starvation responses in this tissue.

**Fig. 6: Fungal heterogeneity in CTR4 expression correlates with IFNg stimulation of host cells.**

IFNγ induces copper restriction in fungal-infected microglia

IFNγ is a pro-inflammatory cytokine that is required for protective immunity against C. neoformans infection²⁵. IFNγ mediates protective crosstalk between CD4 T-cells and macrophages, driving macrophage activation via STAT1 signalling to produce nitric oxide and initiate fungal killing²⁶. IFNγ has also been shown to modulate copper concentrations within macrophage phagosomes inducing either copper deprivation²⁷ or importing excess copper to induce toxicity²⁸. We first explored whether differences in responses to IFNγ could partially explain the increased copper starvation response by yeast internalised within macrophages in contrast to microglia. For that, we compared microglia and macrophages in their production of CXCL9, a canonical chemokine regulated by IFNγ²⁹, as a marker for downstream IFNγ stimulation in the brain using intracellular flow cytometry. Those experiments showed that a significantly higher proportion of macrophages produced CXCL9 compared to microglia (Fig. 6b and Fig S4).

As this data indicated that copper starvation responses of intracellular fungi may correlate with IFNγ stimulation of host cells, we next examined whether IFNγ could modulate copper starvation responses of fungi within microglia. We infected the murine microglia cell line BV-2 with C. neoformans pCTR4-GFP, comparing ^pCTR4GFP expression by yeast internalised within untreated microglia, or microglia pre-treated with IFNγ (Fig. 6c). We found that yeast internalised by IFNγ-treated microglia had significantly higher expression of ^pCTR4GFP than yeast internalised by untreated microglia (Fig. 6d, e). We repeated this experiment using an imaging flow cytometer and independently verified the increased expression and intensity of ^pCTR4GFP by yeast internalised in IFNγ-treated microglia compared to untreated (Fig. 6f). These data suggest that IFNγ induces copper restriction within microglia and macrophage phagosomes resulting in an enhanced fungal copper starvation response.

Tissue-resident microglia and infiltrating myeloid cells have differential abundance of trace metals

Our experiments with the ^pCTR4GFP C. neoformans reporter strain indicated that intracellular residence within different myeloid cell types in the brain has a significant influence on fungal starvation responses. We therefore measured abundance of trace metals that the fungus may acquire from the host in myeloid cell subsets purified from the infected brain to better understand the drivers of this heterogeneity within the fungal population. We found that microglia had lower abundance of iron, magnesium and zinc than monocytes and macrophages, while neutrophils were somewhat variable (Fig. 7a). The limit of sensitivity in these experiments was too low to directly detect copper in purified cells, and hence we can only estimate access to copper within different cell types using the ^pCTR4GFP reporter strain (as shown in Fig. 6a). Instead, we measured copper content in whole brain at various time points post-infection. Those experiments showed that copper content remains relatively stable in the brain throughout infection and does not significantly alter from baseline (Fig. 7b), reflecting the tight homeostatic control on copper levels in tissues. Collectively, these data show that microglia do not appear to have greater abundance of trace metals than other cell types, indicating that differential access to these nutrients may be what drives divergent environmental responses by internalised fungi.

**Fig. 7: C. neoformans CTR4 expression does not correlate with immune cell killing or metal abundance.**

Copper restriction by host myeloid cells does not determine fungal killing capacity

Since yeast within microglia and macrophages in the brain had different rates of ^pCTR4GFP expression (Fig. 6a) and we measured differential abundance of other trace metals in these cell types, we next aimed to determine how host restriction of copper and/or access to other trace metals affected fungal viability and killing by different subpopulations of myeloid cells in the brain. We infected mice with GFP-expressing C. neoformans and used this to identify fungal-infected myeloid cells, as before (Fig. 1). We FACS purified fungal-infected cells and plated known numbers onto fungal growth media, counting the viable colonies that grew to determine rate of fungal killing and intracellular residence in each of the different cell types ex vivo. We found that neutrophils had a high rate of fungal killing and low intracellular residence, since only ~14% of yeast cells were viable from this cell type (Fig. 7c). In contrast, recruited monocytes had high intracellular fungal residence, with ~75% of yeast remaining viable (Fig. 7c). Microglia and macrophages had similar rates of fungal residence and killing capacity, with ~60% of yeast remaining viable in each of these cell types (Fig. 7c). Taken together, this data shows that neutrophils have high fungistatic activity in the brain, while macrophages, monocytes and microglia have similar rates of intracellular fungal growth.

C. neoformans resistance to copper starvation overrides microglia-dependent fungal growth

Our data shows that intracellular fungi within microglia and macrophages have different expression of CTR4, indicating that there are divergent copper starvation responses between these intracellular infection niches. However, these responses did not correlate with fungal killing or abundance of trace metals. Myeloid cell killing may be impeded by fungal adaption to the intracellular environment, including upregulation of transporters to compensate for restricted access to metals such as copper. To better understand the relationship between C. neoformans copper starvation and fungal survival in the brain, we infected mice with C. neoformans mutant strains which are unable to compensate for copper restriction (∆ctr1/∆ctr4) or were insensitive to copper deficiency (CTR4^OE). The ∆ctr1/∆ctr4 C. neoformans strain, which lacks the two major copper importers Ctr1 and Ctr4, has a significantly reduced capacity to infect the mouse brain (compare Fig. 7d with Fig. 2g), likely related to the growth defects of this strain due to the inability to import environmental copper. Importantly, in mice lacking microglia, growth of the ∆ctr1/∆ctr4 mutant was even further restricted, indicating that expression of copper importers by C. neoformans and the presence of microglia are needed to mediate full virulence and infection in the brain (Fig. 7d). In contrast, a copper-insensitive strain of C. neoformans that over-expresses CTR4 was unaffected by the loss of microglia, and we recovered similar fungal burdens from wild-type and microglia-depleted mice (Fig. 7d). Taken together, this data shows that while microglia are not needed for protection against C. neoformans infection, they may influence the phenotype and survival of fungal cells in a manner that is partially dependent on the ability of C. neoformans to scavenge copper and adapt to a copper-restricted environment.

Discussion

Microglia have been shown to play a central role in the protection against CNS infections, including Candida albicans⁴, Toxoplasma gondii³ and viruses². Here, we show that microglia are largely redundant for the control of C. neoformans infection, and may support early C. neoformans growth in the brain of strains with high propensity to grow intracellularly within host myeloid cells. We found that microglia depletion reduces fungal brain infection at the early stages of infection, an effect that was dependent on intracellular growth of the fungus within microglia. While microglia did not contribute towards protection against infection, we found they did play a significant role in influencing the phenotype of fungal cells in the brain. Using a fungal reporter strain to track copper starvation responses, we show that the fungus is protected from copper starvation within microglia, leading to heterogeneity in fungal phenotype between different micro-niches in the brain.

Microglia can rapidly respond to microbial invasion of the CNS. For example, following C. albicans fungal brain infection, microglia produced IL-1β and CXCL1 within 24 hours of infection, which elicited a significant influx of neutrophils to the brain to enable clearance of the infection⁴. During infection with the parasite T. gondii, microglia rapidly produced IL-1α, which was required for the protective recruitment of inflammatory T-cells³. In our work, we found little evidence for a role of microglia in recruiting inflammatory myeloid cells to the CNS during C. neoformans infection, as we observed no consistent difference in the number of recruited neutrophils or monocytes to the infected brain of microglia-depleted mice in any of the models used. This lack of a role for microglia in early protective anti-cryptococcal immunity may be linked with poor induction of pro-inflammatory immune signalling in response to C. neoformans. Many fungi engage CARD9-coupled C-type lectin receptors on host immune cells, leading to a pro-inflammatory signalling cascade and leucocyte activation⁵. However, C. neoformans secretes a mannose-rich capsule which shields the fungal cell wall from recognition by CARD9-coupled receptors, such as Dectin-1³⁰. Indeed, in contrast to other fungal infections, patients with deficiencies in CARD9 and related molecules do not appear to be more susceptible to cryptococcal meningitis⁵, indicating that these pathways are redundant for protection against C. neoformans infection. The innate receptors mediating activation of brain-resident macrophages during C. neoformans infection remains to be determined, but this process likely depends on protective crosstalk with IFNγ-producing CD4 T-cells.

Deficiency or a functional defect in CD4 T-cells is the main risk factor for developing cryptococcal meningitis in humans²⁵. Primary immunodeficiencies linked with cryptococcal meningitis primarily affect the crosstalk between CD4 T-cells and macrophages, such as loss-of-function mutations in IL12RB1³¹ and GATA2³². In each of these cases, patients are thought to be susceptible to cryptococcal meningitis due to the lack of IFNγ-mediated activation of macrophages leading to poor fungal killing and intracellular fungal survival. In a model of chronic C. neoformans brain infection, microglia were activated after significant infiltration of pathologic IFNγ-producing CD4 T-cells which subsequently drove neuroinflammation and death⁸. In another study, treatment of rats with immunostimulatory immunotherapy caused microglial upregulation of MHCII and increased expression of several Toll-like receptors, which coincided with lymphocyte infiltration and fungal clearance⁹. These results indicate that microglia may be unable to respond to C. neoformans infection without T-cell help or immunotherapy. In our study, we have used an acute infection model and examined early time points ( <1 week) prior to significant T-cell infiltration.

In addition to hosting intracellular fungi, microglia may also support infection by enabling fungal invasion across the blood-brain-barrier (BBB). C. neoformans is thought to invade the CNS using a variety of routes, including transcellular invasion of the BBB as free yeast or within host immune cells (e.g. monocytes)³³. Whether microglia are involved with either of these processes is unclear. A small subset of microglia, called capillary-associated microglia (CAMs), have been shown to associate with blood vessels in the brain and are involved in maintaining integrity via purine signalling³⁴. During sterile neuroinflammation, microglia migrate to cerebral blood vessels via CCR5 and drive claudin expression in endothelial cells³⁵, but during sustained or inappropriate inflammation microglia phagocytose components of the BBB and contribute to loss of integrity^35,36. Loss of BBB integrity has been previously observed during cryptococcal meningitis, which is associated with fungal proliferation within cerebral blood vessels leading to rupture³⁷. The role of microglia in BBB integrity during cryptococcal meningitis is still unresolved, and we cannot rule out that the reduction in brain fungal burdens observed in our microglia-depleted mice is partially due to effects on BBB integrity caused by depletion of CAMs and/or interruption of inflammatory microglia migration to the blood vessels. Indeed, we found that depletion of CX3CR1+ cells in the brain at late time points post-infection (which may include inflammatory border macrophages in addition to microglia) continued to reduce brain fungal burden, whereas this effect was absent in our other models. This may reflect differences in the loss of inflammatory subsets of brain macrophages and microglia that are specific to each model. Future studies should therefore examine microglia subsets and migration patterns during fungal infection to identify the different ways in which these cells contribute towards pathology.

Some of the microglia depletion methods used in our study, including the CSF1R inhibitor PLX5622^38,39, are reported to have off target effects on border macrophages within the CNS (e.g. perivascular macrophages). The role of non-microglia CNS border macrophages in the control and dissemination of C. neoformans is not fully understood, but they have been shown to become heavily infected with the fungus and are localised to the main site of disease observed in humans⁴⁰. It is possible that some of the depletion models used in our study may have interrupted fungal invasion tactics that involve these non-microglia populations, contributing to the reduction in fungal brain burdens we observed. To test this possibility, we generated Sall1^CreERCsf1r^flox animals which had specific depletion of microglia while leaving numbers of CNS border macrophages intact. In those animals, fungal burdens were also reduced in the brain, indicating that microglia are the main macrophages within the CNS that promote fungal brain infection at the early stages of infection. Further study is required to specifically examine the function of rarer border macrophages in cryptococcal meningitis and determine whether they contribute towards CNS dissemination and/or prevent fungal invasion across the BBB. For this, we require new models to deplete or manipulate the function of non-microglia macrophage populations in the CNS. Recent work by the Rua lab used an intracranial surgical model to apply PLX5622 directly onto the meninges to deplete macrophages at this border site while leaving brain-resident microglia intact⁴¹. This work revealed the critical role for these macrophages in preventing viral spread into other CNS tissues⁴¹. These novel approaches may prove a useful tool for future studies analysing fungal dissemination into the CNS and the role of the meninges in this process.

When we further examined the phenotype of intracellular yeast cells isolated from microglia, we discovered that the fungus was protected from copper starvation within these cells. Copper is an essential heavy metal critical for mitochondrial respiration and other biochemical processes⁴². C. neoformans strains lacking copper importers (and therefore intracellular copper) are severely restricted in their growth both in the host and laboratory media, which impacts on downstream regulation of growth and classic virulence traits such as iron uptake and melanin production⁴³. Therefore, access to trace metals and micronutrients in different host niches could have a significant influence over fungal virulence and host responses. This concept has been demonstrated for the yeast C. albicans, where growth on different carbon sources affected exposure of immunostimulatory β-glucan within the cell wall which impacted on downstream host responses⁴⁴. In our experiments, we discovered wide variation in the abundance of various elements in microglia and other myeloid cell types in the brain, indicating that the heterogeneity of yeast cells in the brain during infection may be vast. The impact of this on fungal responses to the microenvironment and consequences for pathogenesis will be an important future avenue to explore. It is important to note, however, that high abundance of trace metals may not necessarily reflect greater access by intracellular pathogens, as immune cells can restrict and traffic these elements to cellular compartments that do not contain yeast. It will therefore be critical to assess mammalian shuttling of metals and transporter expression in response to C. neoformans infection and/or cytokine stimulation in future studies.

In addition to the variation in metal abundance and infection rate that we observed across immune cells, it will be important to determine how diversity in C. neoformans isolates affect interaction with brain-resident myeloid cells. We found that infection with non-H99 strains of C. neoformans exhibited different phenotypes in microglia-deficient mice, although all strains showed no dependence on microglia for protection. Indeed, it has been found that there are significant differences across reference strains and clinical isolates in morphology (e.g. ability to form Titan cells)¹⁸, melanin production⁴⁵ and antigenic differences in capsule formation⁴⁶. All of these factors may affect interaction with host immune cells. Careful examination of how different C. neoformans isolates interact with tissue-resident myeloid cells and correlating this information with differences in expression of virulence factors will be an important next step to understand how the role of tissue-resident myeloid cells may be altered by fungal-specific factors.

In the CNS, intracellular copper levels are up to 1000-fold higher than extracellular levels²³. This is likely because copper build-up within the CNS is highly toxic, leading to neuroinflammation of which inappropriate microglia activation is a hallmark⁴². For example, high copper concentrations have been measured in Alzheimer’s plaques⁴⁷, and microglia surrounding those plaques have altered expression of copper transporters linked to pro-inflammatory cytokine responses⁴⁸. Due to the restricted copper availability within the CNS, C. neoformans significantly upregulates copper importing proteins Ctr1 and Ctr4 within the brain^10,24. Expression of these copper importers signifies fungal copper starvation, as they are not expressed when copper conditions are adequate and are required for growth in low copper¹⁰. Indeed, C. neoformans mutants deficient in CTR4 have attenuated growth and virulence specifically within the CNS^10,24.

We tracked C. neoformans copper sensing using a pCTR4-GFP reporter strain. We found that C. neoformans highly upregulated CTR4 in the brain following intravenous infection, confirming previous work that showed C. neoformans is starved of copper in this tissue^10,24,49. However, we found that CTR4 induction was significantly lower in yeast that were associated with microglia. These data indicate that copper concentrations and/or access to copper are higher within microglia. Similar observations have been made with the intracellular replicating fungus Histoplasma capsulatum. H. capsulatum uses the copper importer Ctr3 to protect against copper starvation²⁷, a protein that is functionally related to C. neoformans Ctr4. Infection of bone-marrow derived macrophages in vitro showed that H. capsulatum does not upregulate CTR3 in the phagosome of resting macrophages and can acquire copper from this site, enabling its intracellular infection programme²⁷. IFNγ stimulation of macrophages caused restriction of phagosomal copper concentrations, activating a copper-starvation response in H. capsulatum marked by upregulation of the copper importer CTR3²⁷. In our study, we found evidence of differential responses to IFNγ between microglia and macrophages in the brain, which correlated with expression of CTR4 by intracellular fungi. These data indicate that pro-inflammatory cytokines may regulate access to copper by intracellular pathogens in a cell-type specific manner. However, we did not find differences in the ability of microglia and macrophages to restrict intracellular fungal growth ex vivo. It therefore remains unclear how IFNγ regulates anti-fungal immunity within the brain, and how restricting access to nutrients affects pathogenesis. Indeed, IFNγ was only found to boost fungal killing by macrophages when H. capsulatum lacked expression of CTR3, indicating that although IFNγ can drive nutritional immunity these mechanisms of protection can be subverted by fungal starvation responses that help fuel their intracellular growth and virulence programmes in nutrient restricted conditions. It will be important to discern the effects of IFNγ on different brain-resident myeloid cells during cryptococcal infection in future studies, including how receptor expression and signalling patterns differ between tissue-resident and recruited inflammatory myeloid cells. Adjunctive therapy with recombinant IFNγ in patients with HIV-associated cryptococcal meningitis decreased fungal burden in the CSF, a marker correlated with survival⁵⁰. Yet, the specific protective mechanisms of IFNγ in anti-cryptococcal protection in the CNS are not fully resolved. Our data indicate that IFNγ may exert protective effects directly on microglia, at least partially, by limiting fungal access to key nutrients but the effectiveness of this may depend on fungal adaption to the specific microenvironment encountered within the cell type in question. Future studies will also need to examine other nutrients that the fungus may access within microglia, such as iron and lipids, which have both been shown to be acquired by C. neoformans within other macrophage types^51,52.

In summary, our data highlight microglia as an important reservoir for intracellular fungal infection, acting to shield the fungus from the copper-deficient environment within the CNS. This is one of the first examples of microglia acting to promote CNS infection, and delivers new insights into critical pathways underlying host-fungal interactions in the brain during cryptococcal meningitis.

Methods

Ethics statement

All research complied with local ethical approval. Human tissue biopsies were collected and stored with consent for future research use under a study approved by the REC/Scientific Committee of the Infectious Disease Institute Makere University overseen by the Uganda National Council of Science and Technology. Animal studies were approved by the Animal Welfare and Ethical Review Board at the University of Birmingham and UK Home Office under Project Licence PBE275C33.

Mice

8-12 week old mice (males and females) were housed in individually ventilated cages under specific pathogen free conditions at the Biomedical Services Unit at the University of Birmingham, and had access to standard chow and drinking water ad libitum. Mice were housed under 12 hour light/dark cycle at 20-24°C and 45-65% humidity. Experiments with transgenic mice utilised both males and females to maintain littermate controls. We used female mice for experiments with wild-type mice only, since female mice can be housed in larger groups/smaller cage numbers. Wild-type refers to C57BL/6NCrl (Charles River) or the corresponding littermates of genetically-modified lines; Cx3cr1-Cre^ERRosa26iDTR, Sall1-Cre^ERRosa26^Ai14, and Sall1-Cre^ERCsf1r^flox. Cx3cr1-Cre^ER, Rosa26iDTR, Rosa26^Ai14 and Csf1r^flox mice were originally purchased from Jackson and colonies bred and maintained at the University of Birmingham. Sall1-Cre^ER mice were a kind gift from Dr Melanie Greter (University of Zurich). Mice were euthanised by cervical dislocation at indicated analysis time-points, or when humane endpoints (e.g. 20% weight loss, hypothermia, meningitis) had been reached, whichever occurred earlier.

Tamoxifen and diphtheria toxin treatments

Tamoxifen was dissolved in 100% ethanol (1 g/mL) and diluted in corn oil (Sigma) to 100 mg/mL. Mice received two doses of tamoxifen by oral gavage (10 mg in 100μL) 48 hours apart, prior to infection (experiments using Sall1-Cre^ER crossed strains). In experiments analysing mice at day 6 post-infection, tamoxifen dosing was continued throughout infection with 48 hours between doses as before. In some experiments, mice were left to rest for 5-6 weeks prior to dosing with diphtheria toxin (experiments using Cx3cr1-Cre^ER crossed strains). Diphtheria toxin (Sigma) was injected intraperitoneally (30 ng per gram body weight) daily for 3 days prior to infection, on the day of infection, and for 2 days after.

PLX5622 treatment

PLX5622 (Plexxikon Inc. Berkley, CA) was formulated in AIN-76A rodent chow (Research Diets) at a concentration of 1200 mg/kg. Mice were provided with PLX6522 diet or AIN-76A control diet ad libitum for 1 week prior to infection, and continued throughout the infection study period.

C. neoformans growth and mouse infections

C. neoformans strains used in this study were H99, KN99α-GFP⁵³, rdi1Δ²², ctr1Δ/ctr4Δ¹⁰, CTR4^{OE 10}, B3501⁵⁴, Zc15²¹ and pCTR4-GFP (this study). Yeast was routinely grown in YPD broth (2% peptone [Fisher Scientific], 2% glucose [Fisher Scientific], and 1% yeast extract [Sigma]) at 30 °C for 24 hours at 200 rpm. The ctr1Δ/ctr4Δ mutant was grown in YPD broth supplemented with 10 μm copper sulphate (Fisher). In some experiments, C. neoformans pCTR4-GFP were grown in copper-deficient YNB media (Formedium), supplemented with 2% glucose and copper sulphate (Sigma; see figure legends for specific concentrations). For infections, yeast cells were washed twice in sterile PBS, counted using haemocytometer, and 2x10⁴ yeast injected intravenously into the lateral tail vein. For analysis of brain and lung fungal burdens, animals were euthanized and organs weighed, homogenized in PBS, and serially diluted before plating onto YPD agar supplemented with Penicillin/Streptomycin (Invitrogen). Colonies were counted after incubation at 37 °C for 48 hours.

Generation of pCTR4-GFP C. neoformans

The pCTR4-GFP-mCherry strain was generated by transforming the integrative pCTR4-GFP plasmid¹⁰, which harbours GFP encoding gene driven by copper deficiency inducible promotor (CTR4), into KN99α-mCherry. The mCherry strain was a gift from Dr. Tongbao Liu (Southwest University, China), mCherry expression is controlled by the ACT1 promotor. Transformations of C. neoformans were completed using biolistic transformation, as previously described⁵⁵. The resulting pCTR4-GFP-mCherry strain was validated through growth on copper-sufficient and copper-deficient media to check correct functioning of the ^pCTR4GFP construct.

Analysis of Brain Leukocytes by FACS

Leukocytes were isolated from brain using previously described methods. Briefly, brains were aseptically removed and stored in ice-cold FACS buffer (PBS + 0.5% BSA + 0.01% sodium azide) prior to smashing into a paste using a syringe plunger. The suspension was resuspended in 10 mL 30% Percoll (GE Healthcare), and underlaid with 1.5 mL of 70% Percoll. Gradients were centrifuged at 1000 g for 30 min at 4 °C with the brake off. Leukocytes at the interphase were collected and washed in FACS buffer prior to labelling with fluorophore-conjugated antibodies and flow cytometry analysis. In some experiments, cells were fixed and permeabilised using the eBioscience Foxp3 Staining Buffer Set prior to intracellular staining.

Flow Cytometry

Isolated leukocytes were resuspended in PBS and stained with Live/Dead stain (Invitrogen) on ice as per manufacturer’s instructions. Fc receptors were blocked with anti-CD16/32 and staining with fluorochrome-labelled antibodies (used at 1:200 final dilution) was performed on ice. Labelled samples were acquired immediately or fixed in 2% paraformaldehyde prior to acquisition. Anti-mouse antibodies used in this study were: CD45 (30-F11), CD11b (M1/70), CX3CR1 (SA011F11), MHC Class II (M5/114.15.2), F480 (BM8), Ly6G (1A8), Ly6C (HK1.4), CXCL9 (MIG-2F5.5) all from Biolegend. Samples were acquired on a BD LSR Fortessa equipped with BD FACSDiva v9.0 software. Analysis was performed using FlowJo (v10.6.1, TreeStar).

Sorting of Brain Immune Cells and ex vivo Killing Assay

Mice were infected with GFP-expressing C. neoformans as above, and brain leukocytes isolated at day 7 post-infection. Infected (GFP + ) microglia (CD45^intCX3CR1^hiCD11b⁺), macrophages (CD45^hiCX3CR1⁺CD11b⁺F4/80⁺), monocytes (CD45^hiCD11b⁺Ly6C^hiLy6G^-) and neutrophils (CD45^hiCD11b⁺Ly6G⁺Ly6C^int) were FACS purified using a BD FACS Aria Fusion cytometer under sterile conditions. Collected cells (1000-2000 total) were centrifuged, the pellet resuspended in 1 mL sterile tissue-culture grade water, and samples were then plated onto YPD agar plates (200-300μL per plate). Plates were incubated at 30°C for 2 days prior to colony counting, and killing rate calculated as a percentage of colonies counted over total number of infected cells plated.

Metal Measurements by Inductively-Coupled Plasma Mass Spectrometry (ICP-MS)

Whole brains were added to pre-weighed metal-free falcon tubes (Fisher) containing 1 mL 65% nitric acid diluted in metal-free analytical grade water (Fisher Chemicals). Brains were incubated at 85°C for two hours until dissolved, and then diluted to 8% nitric acid using metal-free water. FACS-purified cells were centrifuged and the pellet resuspended in 100-300μL 65% nitric acid and samples incubated and diluted as above. All samples were analysed on a Perkin Elmer Nexion 300X Mass Spectrometer. Samples were introduced to the ICP at 0.3 mL/minute using a peristatic pump, with a helium flow of 5 mL/minute, and argon gas flow settings as follows: nebuliser 0.9 L/minute, auxiliary gas 1.2 L/minute, plasma gas 18 L/minute. The ICP was run in KED mode with Rf power set at 1600W.

Tissue Culture

BV2 cells (a kind gift from Dr Michail Lionakis, NIH) were routinely maintained at 37 °C, 5% CO₂ in RPMI (supplemented with GlutaMax and HEPES, Gibco), further supplemented with 10% heat-inactivated foetal bovine serum (Gibco) and 1% Penicillin/Streptomycin (Invitrogen), and were split every 2-3 days after reaching 80-90% confluence. For experiments, BV2 cells were lifted using Trypsin-EDTA (Sigma) and a cell scraper, counted using Trypan blue exclusion, and seeded into 12 well plates, at 2x10⁵ cells per well in 1 mL media. In some wells, media was further supplemented with 100 ng/mL recombinant mouse IFNγ (Biolegend). After 24 hours, BV2 cells were infected with 1x10⁶ C. neoformans CTR4^pGFP yeast that had been pre-opsonised with 10μg/mL anti-glucuronoxylomannan (GXM) antibody (18B7; Millipore) for 15 minutes at room temperature. After 2 hours, plates were placed on ice, media removed and replaced with 1 mL ice-cold 2 mM EDTA in 1xPBS. BV2 cells were lifted by gentle pipetting on ice and transferred to FACS tubes prior to staining with fluorophore-conjugated antibodies and 5μg/mL calcofluor white (Sigma), then acquired immediately on a BDFortessa as above.

ImageStream

BV2 cells were seeded into 6-well plates at 1x10⁶ cells per well in 2 mL, and cultured with or without IFNγ as outlined above. BV2 cells were infected at a ratio of 5:1 yeast to cells for two hours prior to lifting and staining as above. Cells were stained and washed in 1.5 mL Eppendorf tubes before resuspending in 100μL 2% paraformaldehyde. Fixed cells were run on an Amnis ImageStream X MkII equipped with three lasers and 6 optical detectors. Final analysis was completed using IDEAS software (version 6.2).

Histopathology

Mouse brains were removed from infected mice at indicated time points and either fixed in 10% formalin for 24 hours before embedding in paraffin wax, or frozen in OCT before sectioning. Tissue sections were stained with periodic Acid-Schiff (PAS) and hematoxylin and eosin (H&E). Imaging of tissue sections were captured using a Zeiss Axio Slide Scanner and data analysed using Zen Lite Blue (version 1.1.2.0).

Confocal Microscopy

Whole mouse brains were fixed in 4% paraformaldehyde for 24 hours at 4 °C then placed in 30% sucrose solution at 4 °C for 24 hours (or until the brain sank), before freezing in OCT (Epredia). Brains were sectioned horizontally (at 30 µm) using a cryostat (Bright Instruments). Slides were washed in ice-cold PBS prior to blocking for 1 hour at room temperature in blocking solution (0.1 M Tris, 1% BSA, 0.1% donkey serum, 0.05% Triton X-100, 0.01% Saponin). Iba-1 antibody (1:500, Wako) staining was performed in blocking solution overnight at 4 °C. Alexa-Fluor 647 secondary antibody (1:500, Thermofisher) was incubated for 2 hours at room temperature and nuclei were stained with DAPI (1:1000). Autofluorescence quenching was performed with the TrueVIEW Autofluorescence Quenching Kit (VectorShield) prior to mounting the slides wit ProLong Gold Antifade mountant (Thermofisher). The slides were imaged using the Zeiss Axio Scan Z1 slide scanner and the Zeiss LSM 880 Confocal with Airyscan Fast. Image analysis was performed using the Zen Blue (v3.1) software.

Statistics

Statistical analyses were performed using GraphPad Prism 9.0 software. Details of individual tests are included in the figure legends. In general, data were tested for normal distribution by Kolmogorov-Smirnov normality test and analysed accordingly by unpaired two-tailed t-test or Mann Whitney U-test. In cases where multiple data sets were analyzed, two-way ANOVA was used with Bonferroni correction. In all cases, P values < 0.05 were considered significant.

Reporting summary

Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.

Data availability

All raw data associated with the figures is available on request, without restrictions. Source data are provided with this paper.

References

Prinz, M., Erny, D. & Hagemeyer, N. Ontogeny and homeostasis of CNS myeloid cells. Nat. Immunol. 18, 385–392 (2017).
Article CAS PubMed Google Scholar
Wheeler, D. L., Sariol, A., Meyerholz, D. K. & Perlman, S. Microglia are required for protection against lethal coronavirus encephalitis in mice. J. Clin. Invest 128, 931–943 (2018).
Article PubMed PubMed Central Google Scholar
Batista, S. J. et al. Gasdermin-D-dependent IL-1α release from microglia promotes protective immunity during chronic Toxoplasma gondii infection. Nat. Commun. 11, 3687 (2020).
Article ADS CAS PubMed PubMed Central Google Scholar
Drummond, R. A. et al. CARD9+ microglia promote antifungal immunity via IL-1β- and CXCL1-mediated neutrophil recruitment. Nat. Immunol. 20, 559–570 (2019).
Article CAS PubMed PubMed Central Google Scholar
Drummond, R. A., Franco, L. M. & Lionakis, M. S. Human CARD9: A Critical Molecule of Fungal Immune Surveillance. Front Immunol. 9, 1836 (2018).
Article PubMed PubMed Central Google Scholar
Mohamed, S. H. et al. Fungal CNS Infections in Africa: The Neuroimmunology of Cryptococcal Meningitis. Front Immunol 13 (2022).
Lee, S. H. C., Kress, Y., Zhao, M. L., Dickson, D. W. & Casadevall, A. Cryptococcus neoformans survive and replicate in human microglia. Lab Investig. 73, 871–879 (1995).
CAS PubMed Google Scholar
Neal, L. M. et al. CD4+ T Cells Orchestrate Lethal Immune Pathology despite Fungal Clearance during Cryptococcus neoformans Meningoencephalitis. mBio 8, e01415–e01417 (2017).
Article CAS PubMed PubMed Central Google Scholar
Hazra, I. et al. T11TS immunotherapy augments microglial and lymphocyte protective immune responses against Cryptococcus neoformans in the brain. Scand. J. Immunol. 89, e12733 (2019).
Article PubMed Google Scholar
Sun, T.-S. et al. Reciprocal functions of Cryptococcus neoformans copper homeostasis machinery during pulmonary infection and meningoencephalitis. Nat. Commun. 5, 5550 (2014).
Article ADS CAS PubMed Google Scholar
Hole, C. & Wormley, F. L. Innate host defenses against Cryptococcus neoformans. J. Microbiol. 54, 202–211 (2016).
Article CAS PubMed Google Scholar
Feldmesser, M., Kress, Y., Novikoff, P. & Casadevall, A. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect. Immun. 68, 4225–4237 (2000).
Article CAS PubMed PubMed Central Google Scholar
Lei, F. et al. CSF1R inhibition by a small-molecule inhibitor is not microglia specific; affecting hematopoiesis and the function of macrophages. Proc. Natl Acad. Sci. 117, 23336–23338 (2020).
Article ADS CAS PubMed PubMed Central Google Scholar
Masuda, T. et al. Specification of CNS macrophage subsets occurs postnatally in defined niches. Nature 604, 740–748 (2022).
Article ADS CAS PubMed Google Scholar
Zhao, X.-F. et al. Targeting Microglia Using Cx3cr1-Cre Lines: Revisiting the Specificity. eNeuro 6, ENEURO.0114-0119.2019 (2019).
Buttgereit, A. et al. Sall1 is a transcriptional regulator defining microglia identity and function. Nat. Immunol. 17, 1397 (2016).
Article CAS PubMed Google Scholar
Jackson, K. M., Ding, M. & Nielsen, K. Importance of Clinical Isolates in Cryptococcus neoformans. Res. J. Fungi (Basel) 9, 364 (2023).
Article CAS Google Scholar
Dambuza, I. M. et al. The Cryptococcus neoformans Titan cell is an inducible and regulated morphotype underlying pathogenesis. PLOS Pathog. 14, e1006978 (2018).
Article PubMed PubMed Central Google Scholar
Sato, K. et al. Production of IL-17A at Innate Immune Phase Leads to Decreased Th1 Immune Response and Attenuated Host Defense against Infection with Cryptococcus deneoformans. J. Immunol. 205, 686 (2020).
Article CAS PubMed Google Scholar
Kwon-Chung, K. J. Morphogenesis of Filobasidiella neoformans, the Sexual State of Cryptococcus neoformans. Mycologia 68, 821–833 (1976).
Article CAS PubMed Google Scholar
Vanhove, M. et al. Genomic epidemiology of Cryptococcus yeasts identifies adaptation to environmental niches underpinning infection across an African HIV/AIDS cohort. Mol. Ecol. 26, 1991–2005 (2017).
Article PubMed Google Scholar
Price, M. S., Nichols, C. B. & Alspaugh, J. A. The Cryptococcus neoformans Rho-GDP dissociation inhibitor mediates intracellular survival and virulence. Infect. Immun. 76, 5729–5737 (2008).
Article CAS PubMed PubMed Central Google Scholar
Gaier, E. D., Eipper, B. A. & Mains, R. E. Copper signaling in the mammalian nervous system: synaptic effects. J. Neurosci. Res 91, 2–19 (2013).
Article CAS PubMed Google Scholar
Ding, C. et al. Cryptococcus neoformans Copper Detoxification Machinery Is Critical for Fungal Virulence. Cell Host Microbe 13, 265–276 (2013).
Article CAS PubMed PubMed Central Google Scholar
Williamson, P. R. et al. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy. Nat. Rev. Neurol. 13, 13–24 (2017).
Article CAS PubMed Google Scholar
Leopold Wager, C. M. et al. STAT1 Signaling within Macrophages Is Required for Antifungal Activity against Cryptococcus neoformans. Infect. Immun. 83, 4513–4527 (2015).
Article PubMed PubMed Central Google Scholar
Shen, Q., Beucler, M. J., Ray, S. C. & Rappleye, C. A. Macrophage activation by IFN-γ triggers restriction of phagosomal copper from intracellular pathogens. PLOS Pathog. 14, e1007444 (2018).
Article PubMed PubMed Central Google Scholar
Djoko, K.Y., Ong, C.-l.Y., Walker, M.J. & McEwan, A.G. The Role of Copper and Zinc Toxicity in Innate Immune Defense against Bacterial Pathogens*. J. Biol. Chem. 290, 18954–18961 (2015).
Article CAS PubMed PubMed Central Google Scholar
Xu, J. et al. Chemokine receptor CXCR3 is required for lethal brain pathology but not pathogen clearance during cryptococcal meningoencephalitis. Sci. Adv. 6, eaba2502 (2020).
Article ADS CAS PubMed PubMed Central Google Scholar
Walsh, N. M., Wuthrich, M., Wang, H., Klein, B. & Hull, C. M. Characterization of C-type lectins reveals an unexpectedly limited interaction between Cryptococcus neoformans spores and Dectin-1. PLoS One 12, e0173866 (2017).
Article PubMed PubMed Central Google Scholar
Rezai, M. S. et al. Cryptococcosis and Deficiency of Interleukin12r. Pediatr. Infect. Dis. J. 27, 673 (2008).
Article PubMed Google Scholar
Vinh, D. C. et al. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood 115, 1519–1529 (2010).
Article CAS PubMed PubMed Central Google Scholar
Santiago-Tirado, F. H., Onken, M. D., Cooper, J. A., Klein, R. S. & Doering, T. L. Trojan Horse Transit Contributes to Blood-Brain Barrier Crossing of a Eukaryotic Pathogen. mBio 8, e02183–16 (2017).
Article CAS PubMed PubMed Central Google Scholar
Bisht, K. et al. Capillary-associated microglia regulate vascular structure and function through PANX1-P2RY12 coupling in mice. Nat. Commun. 12, 5289 (2021).
Article ADS CAS PubMed PubMed Central Google Scholar
Haruwaka, K. et al. Dual microglia effects on blood brain barrier permeability induced by systemic inflammation. Nat. Commun. 10, 5816 (2019).
Article ADS CAS PubMed PubMed Central Google Scholar
Yu, Z. et al. Microglia Regulate Blood–Brain Barrier Integrity via MiR-126a-5p/MMP9 Axis during Inflammatory Demyelination. Advanced Science n/a, 2105442.
Gibson, J. F. et al. Blood vessel occlusion by Cryptococcus neoformans is a mechanism for haemorrhagic dissemination of infection. PLOS Pathog. 18, e1010389 (2022).
Article CAS PubMed PubMed Central Google Scholar
Kerkhofs, D. et al. Pharmacological depletion of microglia and perivascular macrophages prevents Vascular Cognitive Impairment in Ang II-induced hypertension. Theranostics 10, 9512–9527 (2020).
Article CAS PubMed PubMed Central Google Scholar
Spiteri, A. G. et al. PLX5622 Reduces Disease Severity in Lethal CNS Infection by Off-Target Inhibition of Peripheral Inflammatory Monocyte Production. Front. Immunol. 13 (2022).
Kaufman-Francis, K. et al. The early innate immune response to, and phagocyte-dependent entry of, cryptococcus neoformans map to the perivascular space of cortical post-capillary venules in neurocryptococcosis. Am. J. Pathol. 188, 1653–1665 (2018).
Article CAS PubMed Google Scholar
Rebejac, J. et al. Meningeal macrophages protect against viral neuroinfection. Immunity 55, 2103–2117.e2110 (2022).
Article CAS PubMed Google Scholar
Desai, V. & Kaler, S. G. Role of copper in human neurological disorders. Am. J. Clin. Nutr. 88, 855S–858S (2008).
Article CAS PubMed Google Scholar
Ding, C. et al. The copper regulon of the human fungal pathogen Cryptococcus neoformans H99. Mol. Microbiol 81, 1560–1576 (2011).
Article CAS PubMed PubMed Central Google Scholar
Ballou, E. R. et al. Lactate signalling regulates fungal β-glucan masking and immune evasion. Nat. Microbiol. 2, 16238 (2016).
Article CAS PubMed PubMed Central Google Scholar
de Sousa, H. R. et al. Faster Cryptococcus Melanization Increases Virulence in Experimental and Human Cryptococcosis. J. Fungi (Basel) 8, 393 (2022).
Article PubMed Google Scholar
McFadden, D. C., Fries, B. C., Wang, F. & Casadevall, A. Capsule Structural Heterogeneity and Antigenic Variation in Cryptococcus neoformans. Eukaryot. Cell 6, 1464–1473 (2007).
Article CAS PubMed PubMed Central Google Scholar
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L. & Markesbery, W. R. Copper, iron and zinc in Alzheimer’s disease senile plaques. J. Neurol. Sci. 158, 47–52 (1998).
Article CAS PubMed Google Scholar
Zheng, Z. et al. Altered microglial copper homeostasis in a mouse model of Alzheimer’s disease. J. Neurochem 114, 1630–1638 (2010).
Article CAS PubMed PubMed Central Google Scholar
Garcia-Santamarina, S. et al. A lytic polysaccharide monooxygenase-like protein functions in fungal copper import and meningitis. Nat. Chem. Biol. 16, 337–344 (2020).
Article CAS PubMed PubMed Central Google Scholar
Jarvis, J. N. et al. Adjunctive Interferon-γ Immunotherapy for the Treatment of HIV-associated Cryptococcal Meningitis: A Randomized Controlled Trial. AIDS 26, 1105–1113 (2012).
Article CAS PubMed Google Scholar
Nolan, S. J., Fu, M. S., Coppens, I. & Casadevall, A. Lipids Affect the Cryptococcus neoformans-Macrophage Interaction and Promote Nonlytic Exocytosis. Infect. Immun. 85, e00564–00517 (2017).
Article CAS PubMed PubMed Central Google Scholar
Kronstad, J. W., Hu, G. & Jung, W. H. An encapsulation of iron homeostasis and virulence in Cryptococcus neoformans. Trends Microbiol 21, 457–465 (2013).
Article CAS PubMed PubMed Central Google Scholar
Voelz, K., Johnston, S. A., Rutherford, J. C. & May, R. C. Automated analysis of cryptococcal macrophage parasitism using GFP-tagged cryptococci. PLoS One 5, e15968 (2010).
Article ADS CAS PubMed PubMed Central Google Scholar
Kwon-Chung, K. J., Edman, J. C. & Wickes, B. L. Genetic association of mating types and virulence in Cryptococcus neoformans. Infect. Immun. 60, 602–605 (1992).
Article CAS PubMed PubMed Central Google Scholar
Toffaletti, D. L., Rude, T. H., Johnston, S. A., Durack, D. T. & Perfect, J. R. Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J. Bacteriol. 175, 1405–1411 (1993).
Article CAS PubMed PubMed Central Google Scholar

Download references

Acknowledgements

We would like to thank the technical staff at the Biomedical Services Unit (Birmingham) for their care and help with animal husbandry. In particular, we thank Claire Lyons and Karen Boswell for their time and patience performing infections and caring for our animals. We thank Dr Guillaume Desanti and support staff at the Technology Hub and Flow Cytometry Unit at the University of Birmingham for their support with sorting, flow cytometry and microscopy experiments. This work was funded by the Academy of Medical Sciences (SBF004_1008, awarded to RAD), Medical Research Council (MR/S024611, awarded to RAD), Research Foundation Flanders (PhD studentship awarded to EV, 1SF2222N), the National Natural Science Foundation of China (31870140, awarded to CD) and the Wellcome Trust and the Royal Society (211241/Z/18/Z, awarded to ERB).

Author information

Authors and Affiliations

Institute of Immunology & Immunotherapy, University of Birmingham, Birmingham, UK
Sally H. Mohamed, Man Shun Fu, Sofia Hain, Alanoud Alselami, Ebrima Bojang & Rebecca A. Drummond
Department of Imaging and Pathology, Biomedical MRI/MoSAIC, KU Leuven, Leuven, Belgium
Eliane Vanhoffelen & Greetje Vande Velde
College of Life and Health Sciences, Northeastern University, Shenyang, 110015, Liaoning, China
Yanjian Li & Chen Ding
Department of Pathology, College of Health Sciences, Makerere University, Kampala, Uganda
Robert Lukande
MRC Centre for Medical Mycology, University of Exeter, Exeter, UK
Elizabeth R. Ballou
Institute of Microbiology & Infection and School of Biosciences, University of Birmingham, Birmingham, UK
Robin C. May & Rebecca A. Drummond

Authors

Sally H. Mohamed
View author publications
You can also search for this author in PubMed Google Scholar
Man Shun Fu
View author publications
You can also search for this author in PubMed Google Scholar
Sofia Hain
View author publications
You can also search for this author in PubMed Google Scholar
Alanoud Alselami
View author publications
You can also search for this author in PubMed Google Scholar
Eliane Vanhoffelen
View author publications
You can also search for this author in PubMed Google Scholar
Yanjian Li
View author publications
You can also search for this author in PubMed Google Scholar
Ebrima Bojang
View author publications
You can also search for this author in PubMed Google Scholar
Robert Lukande
View author publications
You can also search for this author in PubMed Google Scholar
Elizabeth R. Ballou
View author publications
You can also search for this author in PubMed Google Scholar
Robin C. May
View author publications
You can also search for this author in PubMed Google Scholar
Chen Ding
View author publications
You can also search for this author in PubMed Google Scholar
Greetje Vande Velde
View author publications
You can also search for this author in PubMed Google Scholar
Rebecca A. Drummond
View author publications
You can also search for this author in PubMed Google Scholar

Contributions

S.H.M., M.S.F., S.H., A.A., E.V., Y.L., E.B. and R.A.D. performed the experimental studies. S.H.M., M.S.F., A.A., E.V., E.R.B., R.L., G.V.V. and R.A.D. carried out the analysis. ERB, RCM, CD, GVV and RAD supervised the work. R.L. performed the human pathology studies. R.A.D. obtained the funding. S.H.M., E.R.B., C.D., G.V.V. and R.A.D. conceived and designed experiments. S.H.M. and R.A.D. wrote the manuscript.

Corresponding author

Correspondence to Rebecca A. Drummond.

Ethics declarations

Competing interests

The authors declare no competing interests.

Peer review

Peer review information

Nature Communications thanks the anonymous reviewer(s) for their contribution to the peer review of this work. A peer review file is available.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Information

Peer Review File

Reporting Summary

Source data

Source Data

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Cite this article

Mohamed, S.H., Fu, M.S., Hain, S. et al. Microglia are not protective against cryptococcal meningitis. Nat Commun 14, 7202 (2023). https://doi.org/10.1038/s41467-023-43061-0

Download citation

Received: 13 September 2022
Accepted: 30 October 2023
Published: 08 November 2023
DOI: https://doi.org/10.1038/s41467-023-43061-0

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.